Enhanced Genomics

Enhanced Genomics is a biotechnology company developing a proprietary 3D multi-omics platform that maps genome-wide chromatin interactions to identify genetically validated drug targets for common diseases.

Using patented technology integrated with a human cell type-specific multi-omics atlas, the platform links non-coding disease-associated genetic variants to causal target genes in relevant cell types.

Enhanced Genomics serves pharmaceutical and biotech partners and is building an internal therapeutics pipeline focused on autoimmune conditions.